Health care consumers’ perspectives on pharmacist integration into private general practitioner clinics in Malaysia: A qualitative study

Patient Preference and Adherence

Volumn 9, Issue , 2015, Pages 467-477

  Saw, Pui San ^a   Nissen, Lisa M ^a,b   Freeman, Christopher ^b,c   Wong, Pei Se ^a   Mak, Vivienne ^d  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

General practitioners; Health care consumer; Malaysia; Pharmacist integration; Private clinic

Indexed keywords

ADULT; ARTICLE; CONSUMER ATTITUDE; DRUG INFORMATION; FEMALE; GENERAL PRACTITIONER; HEALTH CARE; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; INFORMATION PROCESSING; MALAYSIA; MALE; MEDICAL FEE; PHARMACIST; PHYSICIAN ATTITUDE; PRIVATE PRACTICE; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW;

EID: 84934972303     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S73953     Document Type: Article

References (44)

1. Jaafar S, Mohd Noh K, Abdul Muttalib K, Othman N, Healy J. Malaysia Health System Review. Health Systems in Transition. 2013;3(1).
2. Wong S. Pharmacy practice in Malaysia. Malaysian Journal of Pharmacy. 2001;(1):2-8.
3. Lim PC, Lim K. Evaluation of a pharmacist-managed diabetes medication therapy adherence clinic. Pharm Pract (Granada). 2010;8(4):250-254.
4. Chua SS, Lim KP, Lee HG. Utilisation of community pharmacists by the general public in Malaysia. Int J Pharm Pract. 2013;21(1):66-69.
5. Ministry of Health (MOH) Malaysia. Country Health Plan: 10th Malaysia Plan 2011-2015. Malaysia: Ministry of Health; 2010. Available from: http://www.moh.gov.my/images/gallery/Report/Country_health.pdf. Accessed December 29, 2014.
6. Malhotra S, Karan RS, Pandhi P, Jain S. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J. 2001;77(913):703-707.
7. Forsyth DR, Chia YC. How should Malaysia respond to its ageing society? Med J Malaysia. 2009;64(1):46-50.
8. Pharmaceutical Services Division, Ministry of Health Malaysia. A National Survey on the Use of Medicines (NSUM) by Malaysian Consumers. Pharmaceutical Services Division, Ministry of Health Malaysia; 2012. Available from: http://www.pharmacy.gov.my/v2/sites/default/files/document-upload/book.national-survey-use-medicines-2.12.pdf. Accessed December 28, 2014.
9. Khan T, Hassali M, Al-Haddad M. Patient-physician Communication Barrier: A Pilot Study Evaluating Patient Experiences. J Young Pharm. 2011;3(3):250-255.
10. Merican MI, bin Yon R. Health care reform and changes: the Malaysia experience. Asia Pac J Public Health. 2002;14(1):17-22.
11. Mohamad Noh K. Primary health care reform in 1 Care for 1 Malaysia. International Journal of Public Health Research Special Issue. 2011:50-56.
12. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ. 2001;323(7325):1340-1343.
13. Zermansky AG, Petty DR, Raynor DK, Lowe CJ, Freemantle N, Vail A. Clinical medication review by a pharmacist of patients on repeat prescriptions in general practice: a randomised controlled trial. Health Technol Assess. 2002;6(20):1-86.
14. McGavock H, Wilson-Davis K, Connolly JP. Repeat prescribing management—a cause for concern? Br J Gen Pract. 1999;49(442):343-347.
15. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002;162(10):1149-1155.
16. Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009; 169(21):1996-2002.
17. Al Mazroui NR, Kamal MM, Ghabash NM, Yacout TA, Kole PL, McElnay JC. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol. 2009;67(5):547-557.
18. Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001;30(3):205-211.
19. Stuijt CC, Franssen EJ, Egberts AC, Hudson SA. Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacist-led medication review. Drugs Aging. 2008;25(11):947-954.
20. Freeman C, Cottrell WN, Kyle G, Williams I, Nissen L. Does a primary care practice pharmacist improve the timeliness and completion of medication management reviews? Int J Pharm Pract. 2012;20(6):395-401.
21. Sheridan J, Butler R, Brandt T, Harrison J, Jensen M, Shaw J. Patients’ and pharmacists’ perceptions of a pilot Medicines Use Review service in Auckland, New Zealand. Journal of Pharmaceutical Health Services Research. 2012;3(1):35-40.
22. Chan DC, Chen JH, Wen CJ, Chiu LS, Wu SC. Effectiveness of the medication safety review clinics for older adults prescribed multiple medications. J Formos Med Assoc. 2014;113(2):106-113.
23. van Mill JW. Pharmaceutical Care in Community Pharmacy: Practice and Research in the Netherlands. Ann Pharmacother. 2005;39(10): 1720-1725.
24. Pharmaceutical Society of Australia Ltd. Guidelines for pharmacists providing Residential Medication Management Review (RMMR) and Quality Use of Medicines (QUM) services. The Pharmaceutical Society of Australia; 2011. Available from: http://www.psa.org.au/download/practice-guidelines/rmmr-and-qum-services.pdf. Accessed January 13, 2015.
25. Midland Community Pharmacy Group. Medicine Management Service in Community Pharmacy. Available from: http://www.midcpg.co.nz/services/medicine-management-service. Accessed November 29, 2014.
26. Bradley F, Elvey R, Ashcroft DM, et al. The challenge of integrating community pharmacists into the primary health care team: a case study of local pharmaceutical services (LPS) pilots and interprofessional collaboration. J Interprof Care. 2008;22(4):387-398.
27. Management Committee. Moving Forward: Pharmacy Human Resources for the Future. Innovative Pharmacy Practices Volume II: Profiles of Pharmacy Practices. Ottawa: Canadian Pharmacists Association; 2008. Available from: http://blueprintforpharmacy.ca/docs/default-document-library/2011/04/19/Innovative_Pharmacy_Practices_Volume_II_final.pdf ?Status=Master. Accessed December 30, 2014.
28. Dolovich L, Pottie K, Kaczorowski J, et al. Integrating family medicine and pharmacy to advance primary care therapeutics. Clin Pharmacol Ther. 2008;83(6):913-917.
29. Management Committee. Moving Forward: Pharmacy Human Resources for the Future. Innovative Pharmacy Practices Volume I: Analysis and Overview. Ottawa: Canadian Pharmacists Association; 2008. Available from: http://blueprintforpharmacy.ca/docs/default-document-library/2011/04/19/Innovative_Pharmacy_Practices_Volume_I_final.pdf?Status=Master. Accessed December 30, 2014.
30. New Zealand Medical Association. Integrated Family Health Centres. New Zealand: NZMA; 2010. Available from: https://www.nzma.org.nz/__data/assets/pdf_file/0020/25517/Integrated-Family-Health-Centres-revised-July-2010.pdf. Accessed December 30, 2014.
31. Freeman C, Cottrell WN, Kyle G, Williams I, Nissen L. Integrating a pharmacist into the general practice environment: opinions of pharmacist’s, general practitioner’s, health care consumer’s, and practice manager’s. BMC Health Serv Res. 2012;12:229.
32. Tan EC, Stewart K, Elliott RA, George J. Stakeholder experiences with general practice pharmacist services: a qualitative study. BMJ Open. 2013;3(9):e003214.
33. Mason M. Sample Size and Saturation in PhD Studies Using Qualitative Interviews. Forum: Qualitative Social Research. 2010;11(3):1.
34. Bedell SE, Jabbour S, Goldberg R, et al. Discrepancies in the use of medications: their extent and predictors in an outpatient practice. Arch Intern Med. 2000;160(14):2129-2134.
35. Bislew HD, Sorensen TD. Use of focus groups as a tool to enhance a pharmaceutical care practice. J Am Pharm Assoc (2003). 2003;43(3):424-433.
36. Iversen L, Mollison J, MacLeod TN. Attitudes of the general public to the expanding role of community pharmacists: a pilot study. Fam Pract. 2001;18(5):534-536.
37. Moore SM, Cairins CJ, Harding G, Craft M. Health promotion in community pharmacy. Int J Pharm Pract. 1996;4:109-116.
38. Gidman W, Ward P, McGregor L. Understanding public trust in services provided by community pharmacists relative to those provided by general practitioners: a qualitative study. BMJ Open. 2012;2(3) pii:e000939.
39. Edmunds J, Calnan MW. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and General Practioners in the United Kingdom. Soc Sci Med. 2001;53(7):943-955.
40. Hughes CM, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract. 2003;53(493):600-606.
41. Blenkinsopp A, Jepson M, Drury M. Using a notification card to improve communication between community pharmacists and general practitioners. Br J Gen Pract. 1991;41(344):116-118.
42. Tan EC, Stewart K, Elliott RA, George J. Integration of pharmacists into general practice clinics in Australia: the views of general practitioners and pharmacists. Int J Pharm Pract. 2014;22(1):28-37.
43. Nominal Fee: Time and knowledge should be compensated, says society chief. The New Straits Times 28 July, 2012. Available from: http://www.mps.org.my/newsmaster.cfm?&menuid=36&action=view&retrieveid=3655. Accessed January 13, 2015.
44. Hargie O, Morrow N, Woodman C. Consumer perceptions of and attitudes to community pharmacy services. Pharmaceutical Journal. 1992;249:688-691.